Literature DB >> 20958854

Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population.

Himanshu P Upadhyaya1, Larry A Kroutil, Deborah Deas, Todd M Durell, David L Van Brunt, Scott P Novak.   

Abstract

There is relatively little research examining motives for nonmedical use (NMU) of attention-deficit/hyperactivity disorder (ADHD) medications and predictors of motivation. We present results of a secondary analysis of an Internet-based epidemiological survey to explore the relationship between stimulant formulation and motivation for NMU of ADHD stimulant medications in a college-aged population. Demographic predictors of motivation to engage in NMU were also explored to investigate the potential correlates of recreational versus performance-enhancement motivations. Respondents scoring higher on the Adult ADHD Self-Report Scale were significantly more likely to engage in NMU of ADHD stimulant medications. Those using extended release (ER) stimulant formulations were less likely to endorse "staying awake" as a reason for NMU compared to those using immediate release (IR) stimulant formulations. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20958854     DOI: 10.1111/j.1521-0391.2010.00078.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  11 in total

1.  Motivations for the nonmedical use of prescription drugs in a longitudinal national sample of young adults.

Authors:  Tess K Drazdowski; Lourah M Kelly; Wendy L Kliewer
Journal:  J Subst Abuse Treat       Date:  2020-04-29

2.  Pursuing Pleasures of Productivity: University Students' Use of Prescription Stimulants for Enhancement and the Moral Uncertainty of Making Work Fun.

Authors:  Margit Anne Petersen; Lotte Stig Nørgaard; Janine M Traulsen
Journal:  Cult Med Psychiatry       Date:  2015-12

3.  Nonmedical use of prescription drugs in adolescents and young adults: not just a Western phenomenon.

Authors:  Silvia S Martins; Lilian A Ghandour
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

Review 4.  The intersection of attention-deficit/hyperactivity disorder and substance abuse.

Authors:  Timothy E Wilens; Nicholas R Morrison
Journal:  Curr Opin Psychiatry       Date:  2011-07       Impact factor: 4.741

5.  Neuropsychological functioning in college students who misuse prescription stimulants.

Authors:  Timothy E Wilens; Nicholas W Carrellas; MaryKate Martelon; Amy M Yule; Ronna Fried; Rayce Anselmo; Sean Esteban McCabe
Journal:  Am J Addict       Date:  2017-06

6.  Acceptability of a Game-Based Intervention to Prevent Adolescent Prescription Opioid Misuse.

Authors:  Alison H Oliveto; Patricia Wright; Nihit Kumar; Srinivasa Gokarakonda; Ian Fischer-Laycock; Joseph Williams; Ronald G Thompson
Journal:  Games Health J       Date:  2022-02-15

7.  Motivations for Prescription Drug Misuse among Young Adults: Considering Social and Developmental Contexts.

Authors:  Amy LeClair; Brian C Kelly; Mark Pawson; Brooke E Wells; Jeffrey T Parsons
Journal:  Drugs (Abingdon Engl)       Date:  2015-04-14

8.  Using structural equation modeling to understand prescription stimulant misuse: a test of the Theory of Triadic Influence.

Authors:  Niloofar Bavarian; Brian R Flay; Patricia L Ketcham; Ellen Smit; Cathy Kodama; Melissa Martin; Robert F Saltz
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

Review 9.  Attention-deficit/hyperactivity disorder in postsecondary students.

Authors:  Kevin Nugent; Wallace Smart
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-26       Impact factor: 2.570

Review 10.  A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.

Authors:  Himanshu P Upadhyaya; Durisala Desaiah; Kory J Schuh; Frank P Bymaster; Mary J Kallman; David O Clarke; Todd M Durell; Paula T Trzepacz; David O Calligaro; Eric S Nisenbaum; Paul J Emmerson; Leslie M Schuh; Warren K Bickel; Albert J Allen
Journal:  Psychopharmacology (Berl)       Date:  2013-02-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.